<DOC>
	<DOCNO>NCT01027143</DOCNO>
	<brief_summary>This project assess effectiveness omega-3 fatty acid supplementation control asthma symptom among obese asthmatic , ass person 's gene influence response treatment ( personalized medicine ) . This project may improve ability treat asthma understand link obesity asthma .</brief_summary>
	<brief_title>Obesity Asthma : Nutrigenetic Response Omega-3 Fatty Acids</brief_title>
	<detailed_description>Obesity increase risk asthma diagnosis child adult . With obesity rise , good understand association may become critically important public health . We determine impact fish oil-derived Eicosapentaenoic acid ( EPA ) Docosahexaenoic acid ( DHA ) asthma control among obese asthmatic . These omega-3 fatty acid show : reduce inflammation important asthma improve asthma outcome inconsistent manner across previous small study - result consistent pharmacogenetic influence . There exist evidence omega-3 fatty acid response display pharmacogenetic response relate ALOX5 genotype . Preliminary data suggest obese individual great risk possess ALOX5 variant thus obese asthmatic may responsive fish oil . We determine ( sub-aim ) exist ALOX5 genotype-related response effect fish oil . This large clinical trial omega-3 fatty acid treatment asthma , first apply pharmacogenetic/nutrigenetic analysis .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Asthma</mesh_term>
	<criteria>age 1225 BMI &gt; 25 ( age 1825 ) BMI % &gt; 85th ( age 1217 ) ( BMI Liberalized ) Physician diagnosis persistent asthma Lung function responsiveness bronchodilator reversibility bronchoprovocation test pregnancy currently take LTRA asthma control serious chronic medical condition bleeding diathesis</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Obesity</keyword>
	<keyword>Pharmacogenetics</keyword>
	<keyword>Nutrigenetics</keyword>
</DOC>